Sio Gene Therapies Inc.
SIOX · NASDAQ
3/31/2022 | 3/31/2021 | 3/31/2020 | 3/31/2019 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $64 | $119 | $81 | $107 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $8 | $13 | $5 | $8 |
| Total Curr. Assets | $72 | $132 | $85 | $115 |
| Property Plant & Equip (Net) | $3 | $2 | $2 | $1 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $6 | $6 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $1 | $0 | $1 |
| Total NC Assets | $3 | $3 | $8 | $8 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $75 | $135 | $94 | $123 |
| Liabilities | – | – | – | – |
| Payables | $4 | $1 | $4 | $2 |
| Short-Term Debt | $1 | $0 | $16 | $21 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | -$21 |
| Other Curr. Liab. | $8 | $9 | $11 | $21 |
| Total Curr. Liab. | $13 | $11 | $32 | $43 |
| LT Debt | $2 | $1 | $0 | $23 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $2 | $1 | $0 | $23 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $15 | $12 | $32 | $66 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$863 | -$791 | -$759 | -$686 |
| AOCI | $0 | $0 | -$0 | $1 |
| Other Equity | $923 | $914 | $820 | $741 |
| Total Equity | $60 | $123 | $62 | $56 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $75 | $135 | $94 | $123 |
| Net Debt | -$61 | -$118 | -$64 | -$63 |